Underwriters granted greenshoe for $10.31 million of additional shares
By Angela McDaniels
Tacoma, Wash., May 26 - Complete Genomics, Inc. priced a public offering of 5.5 million shares of its common stock at $12.50 per share for a total of $68.75 million.
There is an over-allotment option for an additional $10.31 million of stock, according to a company news release.
The price per share is a 6.16% discount to the company's $13.32 closing share price on May 25.
Jefferies & Co., Inc. and UBS Investment Bank are the bookrunners. Baird and Cowen & Co. are acting as co-managers.
Mountain View, Calif.-based Complete Genomics makes a DNA sequencing platform for human genome sequencing and analysis.
| Issuer: | Complete Genomics, Inc.
|
| Issue: | Common stock
|
| Amount: | $68.75 million
|
| Greenshoe: | $10,312,500
|
| Shares: | 5.5 million
|
| Price: | $12.50
|
| Warrants: | No
|
| Agents: | Jefferies & Co., Inc., UBS Investment Bank (bookrunners), Baird, Cowen & Co. (co-managers)
|
| Pricing date: | May 26
|
| Stock symbol: | Nasdaq: GNOM
|
| Stock price: | $13.32 at close May 25
|
| Market capitalization: | $374.82 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
